CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 187 filers reported holding CARA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $191,613 | -54.3% | 39,025 | -0.0% | 0.00% | -50.0% |
| Q4 2022 | $419,279 | +281.2% | 39,039 | +233.7% | 0.01% | +300.0% |
| Q3 2022 | $110,000 | -52.6% | 11,700 | -53.8% | 0.00% | -50.0% |
| Q2 2022 | $232,000 | -67.5% | 25,315 | -56.9% | 0.00% | -63.6% |
| Q1 2022 | $714,000 | +13.9% | 58,733 | +14.1% | 0.01% | +37.5% |
| Q4 2021 | $627,000 | -17.2% | 51,467 | +5.1% | 0.01% | -20.0% |
| Q3 2021 | $757,000 | +48.1% | 48,967 | +36.9% | 0.01% | +66.7% |
| Q2 2021 | $511,000 | +105.2% | 35,760 | +212.7% | 0.01% | +100.0% |
| Q1 2021 | $249,000 | – | 11,435 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |